Literature DB >> 33414086

Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients.

Elton Dajti1, Matteo Renzulli2, Antonio Colecchia3, Maria Letizia Bacchi-Reggiani2, Matteo Milandri2, Benedetta Rossini1, Federico Ravaioli1, Giovanni Marasco1, Luigina Vanessa Alemanni1, Anna Maria Ierardi4, Gianpaolo Carrafiello5, Massimo Pinzani6, Francesco Azzaroli1, Giuseppe Mazzella1, Rita Golfieri2, Davide Festi1.   

Abstract

BACKGROUND: The prognostic role of spontaneous portosystemic shunts (SPSS) has been poorly investigated. AIMS: To evaluate the impact of the presence of SPSS, as well as their characteristics, on the risk of decompensation.
METHODS: This is a retrospective cohort study of 235 advanced chronic liver disease (ACLD) patients with available imaging examination, transient elastography, and upper endoscopy. ACLD was defined as liver stiffness measurement (LSM) >10 kPa. Competitive risk analyses were performed to identify the factors associated with the main outcome.
RESULTS: SPSS were reported in 141 (60%) of the patients. Non-viral etiology was independently associated with SPSS presence [Odds-Ratio (OR): 2.743;95%-Interval-of-Confidence (IC):1.129-6.664]. During a follow-up of 37 (20-63) months, SPSS were found predictors of any decompensation type [Subhazard Ratio (SHR):2.264; 95%-IC:1.259-4.071], independently from a history of decompensation or high-risk-varices presence. The risk of complications was higher in patients with large (SHR: 3.775; 95%-IC: 2.016-7.070) and multiple (SHR:3.832; 95%-IC: 2.004-7.330) shunts, and in those with gastrorenal shunts (SHR:2.636; 95%-IC:1.521-4.569).
CONCLUSIONS: The presence, size, and number of SPSS predict not only the risk of hepatic encephalopathy but that of any type of decompensation across all stages of cirrhosis. Future studies should explore the possibility of treating shunts to prevent decompensation.
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Collaterals; Hepatic encephalopathy; Liver imaging; Portal hypertension

Mesh:

Year:  2021        PMID: 33414086     DOI: 10.1016/j.dld.2020.12.114

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  4 in total

1.  Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.

Authors:  Matteo Renzulli; Nicolò Brandi; Anna Pecorelli; Luigi Vincenzo Pastore; Alessandro Granito; Giuseppe Martinese; Francesco Tovoli; Mario Simonetti; Elton Dajti; Antonio Colecchia; Rita Golfieri
Journal:  Diagnostics (Basel)       Date:  2022-03-29

2.  Determinants of prognosis in cirrhosis: a new outlook.

Authors:  Lorenzo Ridola; Stefania Gioia; Jessica Faccioli; Silvia Nardelli; Oliviero Riggio
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

3.  Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration.

Authors:  Akihisa Tatsumi; Shinya Maekawa; Leona Osawa; Ryo Katoh; Yasuyuki Komiyama; Natsuko Nakakuki; Hitomi Takada; Shuya Matsuda; Masaru Muraoka; Yuichiro Suzuki; Mitsuaki Sato; Ei Takahashi; Mika Miura; Fumitake Amemiya; Shinichi Takano; Mitsuharu Fukasawa; Tatsuya Yamaguchi; Yasuhiro Nakayama; Taisuke Inoue; Hiroki Okada; Takuji Araki; Hiroshi Onishi; Nobuyuki Enomoto
Journal:  JGH Open       Date:  2022-01-28

Review 4.  Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis.

Authors:  Fangfang Yi; Xiaozhong Guo; Qing-Lei Zeng; Benqiang Yang; Yanglan He; Shanshan Yuan; Ankur Arora; Xingshun Qi
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.